BD ChloraPrep Hi-Lite Orange 26 mL Applicator (2% w/v chlorhexidine gluconate (CHG) and 70% v/v I...
FDA Drug Recall #D-0373-2021 — Class I — April 20, 2021
Recall Summary
| Recall Number | D-0373-2021 |
| Classification | Class I — Serious risk |
| Date Initiated | April 20, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | CareFusion 213, LLC |
| Location | El Paso, TX |
| Product Type | Drugs |
| Quantity | 707,050 eaches |
Product Description
BD ChloraPrep Hi-Lite Orange 26 mL Applicator (2% w/v chlorhexidine gluconate (CHG) and 70% v/v Isopropyl alcohol (IPA)) Sterile Solution, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-38
Reason for Recall
Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.
Distribution Pattern
Nationwide within the United States
Lot / Code Information
Lot #: 0108186, Exp. 4/30/2023; 0327867, 0327868, 0328213, 0338656, 0339071, 0328947, 0328949, 0329475, 0329477, 0330457, 0330955, 0330606 0333826, 0333852, 0333855, 0334119, 0335787, 0335792, 0335029, 0336506 0336972, 0336051, 0337245, 0337025, 0338653, 0338542, 0338852, 0339892 0339457, Exp. 11/30/2023
Other Recalls from CareFusion 213, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0243-2026 | Class II | BD ChloraPrep" Triple Swabsticks (Chlorhexidine... | Dec 17, 2025 |
| D-0441-2025 | Class II | BD ChloraPrep Clear, 2% x/v chlorhexidine gluco... | May 15, 2025 |
| D-0259-2025 | Class I | BD ChloraPrep Clear 1mL Applicators, 2% w/v chl... | Feb 14, 2025 |
| D-1168-2023 | Class II | BD ChloraPrep Clear, 2% w/v chlorhexidine gluco... | Aug 25, 2023 |
| D-0350-2021 | Class II | ChloraPrep With Tint 2% w/v chlorhexidine gluco... | Mar 19, 2021 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.